Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$8.54B |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$6.22B |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$6.12B |
| 4 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$5.39B |
| 5 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$5.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$367M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$335M |
| 3 |
Diageo
DEO
|
+$297M |
| 4 |
Medtronic
MDT
|
+$259M |
| 5 |
GE Aerospace
GE
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.36% |
| 2 | Financials | 10.66% |
| 3 | Healthcare | 9.68% |
| 4 | Consumer Discretionary | 8.35% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Mitek Systems
MITK
$754M
| $1.43M | ﹤0.01% |
128,321
+11,750
| +10% | +$150K |
|
2802
Consumer Portfolio Services
CPSS
$202M
| $1.43M | ﹤0.01% |
146,364
+121,437
| +487% | +$1.03M |
|
2803
Equity Bancshares
EQBK
$1.04B
| $1.43M | ﹤0.01% |
40,745
+1,413
| +4% | +$47.3K |
|
2804
i3 Verticals
IIIV
$412M
| $1.43M | ﹤0.01% |
64,946
+3,671
| +6% | +$77.4K |
|
2805
Holley
HLLY
$321M
| $1.43M | ﹤0.01% |
400,416
-4,789
| -1% | -$18.7K |
|
2806
AlTi Global
ALTI
$399M
| $1.42M | ﹤0.01% |
273,260
+69,725
| +34% | +$335K |
|
2807
ALX Oncology
ALXO
$261M
| $1.42M | ﹤0.01% |
236,020
+26,261
| +13% | +$323K |
|
2808
Regional Management Corp
RM
$301M
| $1.42M | ﹤0.01% |
49,367
-19,319
| -28% | -$523K |
|
2809
EverQuote
EVER
$892M
| $1.41M | ﹤0.01% |
67,697
+10,403
| +18% | +$220K |
|
2810
Global Ship Lease
GSL
$1.6B
| $1.41M | ﹤0.01% |
49,036
-15,283
| -24% | -$388K |
|
2811
Tactile Systems Technology
TCMD
$635M
| $1.41M | ﹤0.01% |
117,690
+55,228
| +88% | +$743K |
|
|
PAL
2812
Proficient Auto Logistics
PAL
$190M
| $1.4M | ﹤0.01% |
+87,421
| New | +$1.33M |
|
2813
SES AI
SES
$203M
| $1.39M | ﹤0.01% |
1,115,334
+88,784
| +9% | +$120K |
|
2814
Cerence
CRNC
$385M
| $1.39M | ﹤0.01% |
491,697
-51,647
| -10% | -$368K |
|
2815
UroGen Pharma
URGN
$1.86B
| $1.39M | ﹤0.01% |
82,917
+20,037
| +32% | +$285K |
|
2816
Amalgamated Financial
AMAL
$1.47B
| $1.39M | ﹤0.01% |
50,690
+3,539
| +8% | +$86.4K |
|
2817
Omega Flex
OFLX
$297M
| $1.39M | ﹤0.01% |
27,020
+1,022
| +4% | +$65.2K |
|
2818
Hagerty
HGTY
$1.17B
| $1.38M | ﹤0.01% |
132,775
-13,018
| -9% | -$121K |
|
2819
Paysafe
PSFE
$414M
| $1.38M | ﹤0.01% |
77,811
+5,377
| +7% | +$89.5K |
|
2820
Altimmune
ALT
$552M
| $1.38M | ﹤0.01% |
206,854
+64,149
| +45% | +$473K |
|
|
SMLR
2821
DELISTED
Semler Scientific
SMLR
| $1.37M | ﹤0.01% |
39,898
+767
| +2% | +$22.1K |
|
2822
Stem
STEM
$48.4M
| $1.37M | ﹤0.01% |
61,557
+2,762
| +5% | +$80.9K |
|
2823
Rimini Street
RMNI
$445M
| $1.37M | ﹤0.01% |
444,881
+10,878
| +3% | +$29.9K |
|
2824
Wave Life Sciences
WVE
$1.09B
| $1.36M | ﹤0.01% |
273,272
-160,305
| -37% | -$915K |
|
2825
Millicom
TIGO
$16B
| $1.36M | ﹤0.01% |
+55,409
| New | +$1.24M |
|
Similar funds
Charles Schwab's Q2 2024 Portfolio in Review
As of Q2 2024, Charles Schwab held 3,738 positions worth $525B, up 21% from $433B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Charles Schwab deployed $84.3B of net new capital in Q2 2024, opening 263 new positions and adding to 2,391 existing holdings. Its largest new stake was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Texas Instruments, an estimated $367M trimmed.
- Charles Schwab's largest Q2 2024 buy was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
- Charles Schwab added most to Schwab Fundamental US Large Company Index ETF in Q2 2024, an estimated $8.54B increase.
- Charles Schwab's biggest Q2 2024 reduction was Texas Instruments, cutting an estimated $367M.
- Charles Schwab fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $335M.
- Charles Schwab's ten largest holdings make up 21% of its $525B portfolio in Q2 2024.
- Charles Schwab opened 263 new positions and closed 116 in Q2 2024.
- Charles Schwab's portfolio value rose 21% quarter-over-quarter to $525B.
Based on Charles Schwab's 13F filing for Q2 2024, filed 12 Aug 2024.